Measuring the loss of consumer choice in mandatory health programmes using discrete choice experiments

Applied Health Economics and Health Policy

Volumn 11, Issue 2, 2013, Pages 139-150

  Parkinson, Bonny ^a   Goodall, Stephen ^a   Norman, Richard ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; INFLUENZA VACCINE; TRANS FATTY ACID;

ADULT; ANALYTIC METHOD; ARTICLE; CHILD; CLINICAL PROTOCOL; CONSUMER; CONTROLLED STUDY; CORRELATION COEFFICIENT; COST UTILITY ANALYSIS; DECISION MAKING; DISCRETE CHOICE EXPERIMENT; DRUG EFFICACY; ECONOMIC EVALUATION; FACTORIAL DESIGN; FEMALE; FLOUR; FOOD PROCESSING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; BREAD; CHILD; CHILD, PRESCHOOL; CHOICE BEHAVIOR; CONSUMER SATISFACTION; FEMALE; FOLIC ACID; HEALTH CARE COSTS; HUMANS; INFANT; MALE; MANDATORY PROGRAMS; MIDDLE AGED; TRANS FATTY ACIDS; VACCINATION; VOLUNTARY PROGRAMS; YOUNG ADULT;

EID: 84877026334     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-013-0017-1     Document Type: Article

References (61)

1. Productivity Commission. Impacts of advances in medical technology in Australia, Research Report. Melbourne: Productivity Commission; 2005.
2. Banks G. Health costs and policy in an ageing Australia, Health Policy Oration 2008, Menzies Centre for Health Policy, John Curtin School of Medical Research, ANU, Canberra, 2008 Jun 26 [online]. http://www.pc.gov.au/-data/ assets/pdf-file/0011/81758/cs20080701-agedhealthpolicy.pdf [Accessed 2012 Oct 10].
3. Oakley G, Johnston R. Balancing benefits and harms in public health prevention programmes mandated by governments. BMJ. 2004;329:41-3.
4. Segal L, Dalziel K, Katz R. Informing a strategy for increasing folate levels to prevent neural tube defects: a cost-effectiveness analysis of options: a report for Food Standards Australia and New Zealand, Monash University and University of South Australia, ed. Food Standards Australia and New Zealand; 2007.
5. Access Economics. Cost benefit analysis of fortifying the food supply with iodine: Report for Food Standards Australia and New Zealand. Canberra: Access Economics; 2006.
6. Goodall S, Norman RP, Gallego G. Cost-effectiveness analysis of alternate strategies to address iodine deficiency in Australia, CHERE Project Report for the Department of Health and Ageing, Australian Government. Sydney: CHERE; 2007. p. 1-99.
7. Parkinson B, Goodall S. Considering consumer choice in the economic evaluation of mandatory health programmes: a review. Health Policy. 2011;101(3):236-44.
8. Coughlin S. Ethical issues in epidemiologic research and public health practice. Emerg Themes Epidemiol. 2006;3:16.
9. Beauchamp T, Childress J. Principles of biomedical ethics. 4th ed. New York: Oxford University Press; 1996.
10. Wagstaff A, van Doorslaer E. Equity in health care finance and delivery. In: Culyer A, Newhouse J, editors. Handbook of health economics. Oxford: Elsevier; 2000.
11. Nozick R. Anarchy, state, and utopia. New York: Basic Books; 1975.
12. Williams A, Cookson R. Equity in Health. In: Culyer A, Newhouse J, editors. Handbook of health economics. Oxford: Elsevier; 2000.
13. Brouwer W, van Exel N, van den Berg B, van den Bos G, Koopmanschap M. Process utility from providing informal care: the benefit of caring. Health Policy. 2005;74(1):85-99.
14. Sen A. Development as freedom. Oxford: Oxford University Press; 1999.
15. Thaler R, Shefrin H. An economic theory of self-control. J Polit Econ. 1981;89(2):392-406.
16. Lancaster K. A new approach to consumer theory. J Polit Econ. 1966;74(2):132.
17. Ryan M, Gerard K, Currie G. Using discrete choice experiments in health economics. In: Jones A, editor. The Elgar companion to health economics. Cheltenham: Edward Elgar Publishing Ltd; 2006. p. 405-14.
18. Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55-64.
19. Lancsar E, Savage E. Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory. Health Econ. 2004;13(9):901-7.
20. Ryan M. Deriving welfare measures in discrete choice experiments: a comment to Lanscar and Savage (I). Health Econ. 2004;13:909-12.
21. Santos Silva J. Deriving welfare measures in discrete choice experiments: a comment to Lancsar and Savage (2). Health Econ. 2004;13(9):913-8 (discussion 9-24).
22. Lancsar E, Savage E. Deriving welfare measures from discrete choice experiments: a response to Ryan and Santos Silva. Health Econ. 2004;13(9):919-24.
23. Mark T, Swait J. Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Econ. 2004;13:563-73.
24. Australian Bureau of Statistics, Occasional paper: Measuring dietary habits in the 2001 National Health Survey, 4814.0.55.001. Canberra: ABS; 2003.
25. Abeywardana S, Sullivan E. Neural tube defects in Australia: an epidemiological report. Cat. no. PER 45. Sydney: AIHW National Perinatal Statistics Unit; 2008.
26. Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis. 2004;190:1369-73.
27. Piedra P, Gaglani M, Kozinetz C, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005;23(13):1540-8.
28. Tuckerman J, Rajesh S, Oeppen C, et al. Review of the evidence of the effectiveness and cost effectiveness of interventions to address differences in the uptake of immunisations (including targeted vaccines) in people younger than 19 years: synopsis for consultation 24 September-22 October 2008. London: National Collaborating Centre for Women's and Children's Health; 2008.
29. Hall J, Kenny P, King M, Louvier J, Viney R, Yeoh A. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Econ. 2002;2002(11):457-65.
30. Bentley T, Weinstein M, Willett W, Kuntz K. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr. 2009;12(4):455-67.
31. Romano P, Waitzman N, Scheffler R, Pi R. Folic acid fortification of grain: an economic analysis. Am J Public Health. 1995;85(5):667-76.
32. Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet. 2005;365(9461):773-80.
33. ATAGI. Influenza. In: The Australian immunisation handbook. Canberra: Department of Health and National Health and Medical Research Council; 2008. p. 184-94.
34. Vynnycky E, Pitman R, Siddiqui R, Gay N, Edmunds W. Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine. 2008;26:5321-30.
35. Brotherton J, Wang H, Schaffer A, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence, Australian Department of Health and Ageing. 2007;31(Suppl.):viii- S152.
36. Mozaffarian D, Katan M, Ascherio A, Stampfer M, Willett W. Trans fatty acids and cardiovascular disease. New Eng J Med. 2006;354(15):1601.
37. Australian Institute of Health and Welfare. AIHW National Mortality Database. 2006 [online] http://www.aihw.gov.au/aihw-national-mortality-database/ [cited 2010 8 March 2010].
38. Dixon S, Shackley P. Estimating the benefits of community water fluoridation using the willingness-to-pay technique: results of a pilot study. Commun Dent Oral Epidemiol. 1999;27:124-9.
39. Dixon S, Shackley P. The use of willingness to pay to assess public preferences towards the fortification of foodstuffs with folic acid. Health Expect. 2003;6:140-8.
40. Kuhfeld W. Orthogonal arrays. 2010 [online]. http://support.sas.com/ techsup/technote/ts723.html [Accessed 2010 Feb 23].
41. Burgess L. Discrete choice experiments [computer software], 2007 [online]. http://crsu.science.uts.edu.au/choice/ [Accessed 2010 Feb 23].
42. McFadden D. Conditional logit analysis of qualitative choice behaviour. In: Zarembka P, editor. Frontiers in econometrics. New York: Academic Press; 1974. p. 105-42.
43. McFadden D, Train K. Mixed MNL models for discrete response. J Appl Econ. 2000;15:447-70.
44. Fiebig D, Keane M, Louvier J, Wasi N. The generalized multinomial logit model: accounting for scale and coefficient heterogeneity. Market Sci. 2010;29(3):393-421.
45. Train K. Discrete choice methods with simulation. 2nd ed. Cambridge: Cambridge University Press; 2009.
46. Lancsar E, Louviere J. Deleting 'irrational' responses from discrete choice experiments: a case of investigating or imposing preferences? Health Econ. 2006;15(8):797-811.
47. Flynn T. Using conjoint analysis and choice experiments to estimate QALY values: issues to consider. Pharmacoeconomics. 2010;28(9):711-22.
48. Baker R, Bateman I, Donaldson C, et al. Weighting and valuing quality adjusted life years: preliminary results from the Social Value of a QALY Project. Newcastle: Institute of Health and Society, Newcastle University; 2008.
49. Shackley P, Dixon S. Using contingent valuation to elicit public preferences for water fluoridation. Appl Econ. 2000;32:777-87.
50. Claxton K, Walker S, Palmer S, Sculpher M. Appropriate perspectives for health care decisions. In: CHE Research Paper 54. York: The University of York, Centre for Health Economics; 2010.
51. Pharmaceutical Benefits Advisory Committee, Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3). Canberra: Australian Government, Department of Health and Ageing; 2008.
52. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE; 2008.
53. HM Treasury. The green book: appraisal and evaluation in central government. London: TSO; 2003.
54. Office of Best Practice Regulation (OBPR). Best practice regulation handbook. Canberra: Australian Government; 2007.
55. Australian Bureau of Statistics. Population by age and sex, Australian states and territories, 3201.0. Canberra: ABS; 2009.
56. Australian Bureau of Statistics, Aspects of social capital, 4911.0. Canberra: ABS; 2006.
57. Australian Bureau of Statistics, Labour force, 6202.0. Canberra: ABS; 2010.
58. Australian Bureau of Statistics, Family characteristics and transitions, 4442.0 Canberra: ABS; 2006-2007.
59. Australian Bureau of Statistics, Education and work, Australia, 6227.0. Canberra: ABS; 2008.
60. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001(3).
61. Food Standards Australia New Zealand. Intakes of trans fatty acids in New Zealand and Australia: Review Report, Item 3.6. Canberra: FSANZ; 2008.